What concerns does the NHRC have regarding the circulation of drugs in India
The NHRC is alarmed over reported circulation of falsified liver and cancer drugs.
The NHRC (National Human Rights Commission) in India has expressed concerns about the circulation of drugs in the country, particularly relating to falsified liver and cancer drugs. The following points highlight the concerns raised by the NHRC:
- Falsified drugs: The NHRC is alarmed by reports of the circulation of falsified drugs, including those used for treating liver and cancer ailments.
- Public health risks: The distribution of falsified drugs poses significant risks to the public health of individuals who rely on these medications for treating serious medical conditions.
- Economic exploitation: The circulation of falsified drugs also represents a major form of economic exploitation, where vulnerable patients end up paying for ineffective or even harmful medications.
- Criminal networks: The NHRC is concerned about the criminal networks involved in the production, distribution, and sale of falsified drugs and the potential impact this has on healthcare systems and patient safety.
- Regulatory framework: The NHRC emphasizes the need for strict regulation and effective enforcement to address these issues and ensure the availability of genuine and safe drugs for patients.
Answered
a year ago